Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial

Colaboración

Año: 2025

Gion, M; Blancas, I; Cortez-Castedo, P; Cortes-Salgado, A; Marme, F; Blanch, S; Morales, S; Diaz, N; Calvo-Plaza, I; Recalde, S; Martinez-Bueno, A; Ruiz-Borrego, M; Llabres, E; Taberner, MT; de Laurentiis, M; Garcia-Vicente, S; Guerrero, JA; Boix, O; Rodriguez-Morato, J; Sampayo-Cordero, M; Antonarelli, G; Perez-Garcia, JM; Cortes, J; Llombart-Cussac, A

Título: NATURE MEDICINE

• D1